Dependency of cortisol suppression on administration time of inhaled corticosteroids

Journal of Clinical Pharmacology

Volumn 37, Issue 8, 1997, Pages 704-710

  Meibohm, Bernd ^a   Hochhaus, Günther ^a   Rohatagi, Shashank ^a   Möllmann, Helmut ^b   Barth, Jürgen ^b   Wagner, Melanie ^b   Krieg, Michael ^b   Stöckmann, Ricarda ^b   Derendorf, Hartmut ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNISOLIDE; FLUTICASONE PROPIONATE;

ARTICLE; ASTHMA; CIRCADIAN RHYTHM; CORTICOSTEROID THERAPY; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; HYDROCORTISONE RELEASE; INHALATIONAL DRUG ADMINISTRATION;

EID: 0030866260     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04357.x     Document Type: Article

References (31)

1. Barnes P: Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-875.
2. Brattsand R, Thalen A, Roempke K, Kallstrom L, Gruvstad E: Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. Eur J Respir Dis 1982;122(suppl):62-73.
3. Phillipps GH: Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990;84:19-23.
4. Barnes PJ, Pedersen S: Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148(suppl):S1-S26.
5. Kamada A, Szefler S, Martin R, Boushey H, Chinchilli V, Drazen J, et al: Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 1996;153:1739-1748.
6. Honour J: Hypothalamic-pituitary-adrenal axis. Respir Med 1994;88:9-15.
7. Sherman B, Wysham C, Pfohl B: Age-related changes in the circadian rhythm of plasma cortisol in man. J Clin Endocrinol Metab 1985;61:439-443.
8. DiRaimondo V: Some implications of the spontaneous diurnal variation in adrenal cortical secretory activity. Am J Med 1956;21:321-323.
9. Nichols T, Nugent CA, Tyler FH: Diurnal variation in suppression of adrenal function by glucocorticoids. J Clin Endocrinol 1965;25:343-349.
10. Segre EJ, Klaiber EL: Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity. California Med 1966;104:363-365.
11. Grant S, Forsham P, DiRaimondo V: Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. N Engl J Med 1965;273:1115-1117.
12. Reinberg A, Guillet P, Gervais P, Ghata J, Vignaud D, Abulker C: One month chronocorticotherapy (Dutimelan 8 15 mite): control of the asthmatic condition without adrenal suppression and circadian rhythm alteration. Chronobiologia 1977;4:295-312.
13. Reinberg A, Halberg F, Falliers CJ: Circadian timing of methyl-prednisolone effects in asthmatic boys. Chronobiologia 1974;1:333-347.
14. Reinberg A, Gervais P, Chassade M, Fradoulet G, Duburque B: Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol 1983;71:425-433.
15. Beam WR, Weiner DE, Martin RJ: Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992;146:1524-1530.
16. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ: Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995;95:1172-1178.
17. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ: Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991;88:572-580.
18. Rohatagi S, Hochhaus G, Möllmann H, Barth J, Galia E, Erdmann M, et al: Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral and inhaled administration. J Clin Pharmacol 1995;35:1187-1193.
19. Rohatagi S, Bye A, Falcoz C, Mackie AE, Meibohm B, Möllmann H, Derendorf H: Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate. J Clin Pharmacol 1996;36:938-941.
20. Möllmann H, Derendorf H, Barth J, Meibohm B, Wagner M, Krieg M, et al: Pharmacokinetic/pharmacodynamic evaluation of the systemic effects of flunisolide after inhalation. J Clin Pharmacol (in press).
21. Möllmann H, Meibohm B, Hochhaus G, Barth J, Falcoz C, Wagner M, et al: Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. Eur J Clin Pharmacol (in press).
22. Meibohm B, Hochhaus G, Möllmann H, Barth J, Wagner M, Krieg M, et al: A PK/PD-approach to predict the cumulative cortisol suppression of inhaled corticosteroids. J Pharmacokinet Biopharm (submitted).
23. Rohatagi S, Bye A, Mackie AE, Derendorf H: Mathematical modeling of cortisol circadian rhythm and cortisol suppression. Eur J Pharm Sci 1996;4:341-350.
24. Derendorf H, Möllmann H, Barth J, Möllmann C, Tunn S, Krieg M: Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol 1991;31:473-476.
25. Reinberg A, Smolensky MH, GE DA, McGovern JP: Chronobiology and asthma: III. Timing corticotherapy to biological rhythms to optimize treatment goals. J Asthma 1988;25:219-248.
26. Levy G: Relationship between elimination rate of drugs and rate of decline of their pharmacologic effects. J Pharm Sci 1964;53:342-343.
27. Hochhaus G, Derendorf H: Dose optimization based on pharmacokinetic-pharmacodynamic modeling. In, Derendorf H, Hochhaus G (eds.): Handbook of Pharmacokinetic/Pharmacodynamic Correlation. Boca Raton, FL: CRC Press, 1995;79-120.
28. Corren J, Rachelefsky G, Hochhaus G: A five-way parallel randomized study to compare the safety profile of beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate, and triamcinolone acetonide in healthy male volunteers. Chest 1996;110:833.
29. Wiessmann K, Trautmann M: Fluticasone propionate (500 μg daily) and flunisolide (1000 μg daily) in the treatment of steroid-naive patients with moderate asthma. Eur Respir J 1994;7:383S.
30. Würthwein G, Rehder S, Rohdewald P: Lipophilicity and receptor affinity of glucocorticoids. Pharm Ztg Wiss 1992;137:161-167.
31. Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr, Jusko WJ: Pharmacokinetics and pharmacodynamics of methyl-prednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther 1992;51:677-688.